Related Experiment Video
Updated: Jun 19, 2025

06:19
Author Spotlight: Advancing SERS Technology: Au@Carbon Dot Nanoprobes for Label-Free Analysis and Imaging
Published on: June 9, 2023
1.5K
Dual-responsive electrochemical immunosensor for CYFRA21-1 detection based on Au/Co Co-loaded 3D ordered macroporous
Qi Shen1, Jianjun Ding1, Zengsheng Guo1
1School of Chemistry and Chemical Engineering, University of Jinan, Jinan 250055, PR China.
Colloids and Surfaces. B, Biointerfaces
|July 25, 2024
Summary
A novel electrochemical immunosensor was developed to accurately detect cytokeratin-19 fragment antigen 21-1 (CYFRA21-1), a key biomarker for non-small cell lung cancer. This advanced sensor utilizes a unique 3D carbon structure with gold-cobalt nanoparticles for enhanced sensitivity and reliable detection in human serum.
Area of Science:
- Electrochemistry
- Nanomaterials Science
- Biomedical Engineering
Background:
- Cytokeratin 19 fragment antigen 21-1 (CYFRA21-1) is a crucial biomarker for non-small cell lung cancer (NSCLC).
- Accurate and sensitive detection of CYFRA21-1 is vital for early diagnosis and patient management.
- Existing detection methods may face limitations in sensitivity or specificity.
Purpose of the Study:
- To develop a novel, label-free electrochemical immunosensor for the sensitive and accurate detection of CYFRA21-1.
- To utilize a unique 3D ordered interconnecting macroporous carbon skeleton material modified with gold-cobalt nanoparticles (Au/Co NPs-3D MCF).
- To evaluate the performance of the developed immunosensor in detecting CYFRA21-1 in human serum.
Main Methods:
- Fabrication of a 3D ordered interconnecting macroporous carbon skeleton.
- Modification of the carbon skeleton with gold-cobalt nanoparticles (Au/Co NPs).
- Immobilization of antibodies for CYFRA21-1 detection and electrochemical analysis using chronocurrent testing and square-wave voltammetry.
Main Results:
- The Au/Co NPs-3D MCF immunosensor demonstrated a high specific surface area and enhanced electrochemical activity.
- Achieved a wide linear response range from 0.0001-100 ng/mL for CYFRA21-1 detection.
- Exhibited a low limit of detection and successful detection of CYFRA21-1 in human serum samples.
Conclusions:
- The developed dual-responsive label-free electrochemical immunosensor offers high sensitivity and selectivity for CYFRA21-1 detection.
- The unique 3D nanostructure and synergistic effects of Au/Co NPs significantly enhance sensor performance.
- This platform holds potential for early NSCLC diagnosis and can be extended for multiplexed biomarker detection.

